GALE - Galena Biopharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.52M
Enterprise Value 38.49M
Trailing P/E -0.25
Forward P/E 1-0.45
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.74
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.36

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)0.00%
Management Effectiveness
Return on Assets (ttm)-21.97%
Return on Equity (ttm)-79.40%
Income Statement
Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.48M
Net Income Avi to Common (ttm)-15.66M
Diluted EPS (ttm)-1.52
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)18.07M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)13.03M
Total Debt/Equity (mrq)68.10
Current Ratio (mrq)0.94
Book Value Per Share (mrq)0.51
Cash Flow Statement
Operating Cash Flow (ttm)-40.17M
Levered Free Cash Flow (ttm)-989.88k

Trading Information

Stock Price History
Beta 2.33
52-Week Change 344.33%
S&P500 52-Week Change 319.45%
52 Week High 34.7500
52 Week Low 30.1600
50-Day Moving Average 30.3714
200-Day Moving Average 30.4994
Share Statistics
Avg Vol (3 month) 3671.83k
Avg Vol (10 day) 3515.42k
Shares Outstanding 538.41M
Float 25.13M
% Held by Insiders 14.46%
% Held by Institutions 128.27%
Shares Short 34.61M
Short Ratio 38.58
Short % of Float 312.37%
Shares Short (prior month) 34.56M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Nov 14, 2016